ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Study identifies potential approach to treat patients with severe COVID-19
June 08, 2020Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. -
China’s BeiGene delays US filing for rival to Imbruvica
December 05, 2018BeiGene’s plans for an early approval for BTK inhibitor zanubrutinib in the US and to start challenging Janssen/AbbVie’s blockbuster Imbruvica have suffered a setback.
Pharma Sources Insight January 2025
